Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$11.20M
9 trades · 1 insiders
Net · 90d
$-11.20M
Insiders on file
52
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| CAGNONI PABLO J | President, R&D | 75 | $0 | $23.06M | 2026-10-15 |
| Heeson Lee | EVP, Head of Incyte Intl | 10 | $0 | $289.0K | 2026-10-01 |
| Clancy Paul J | Director | 56 | $0 | $1.42M | 2026-09-30 |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 28 | $13.20M | $0 | 2026-09-30 |
| HARRIGAN EDMUND | Director | 44 | $0 | $0 | 2026-09-30 |
| Gardner David H | EVP, Chief Strategy Officer | 8 | $0 | $0 | 2026-09-22 |
| Basi Ramitpal K | EVP, Human Resources | 8 | $0 | $0 | 2026-08-25 |
| Mayes Patrick A | EVP & Chief Scientific Officer | 104 | $0 | $12.57M | 2026-08-05 |
| Morrissey Michael James | EVP, Head of Tech. Operations | 41 | $0 | $7.30M | 2026-07-23 |
| Hoffman Richard A. | EVP & General Counsel | 6 | $0 | $0 | 2026-07-16 |
| Issa Mohamed Khairie | EVP, Head of US Oncology | 13 | $0 | $1.31M | 2026-07-16 |
| Tray Thomas | Principal Accounting Officer | 49 | $0 | $1.51M | 2026-07-16 |
| Stein Steven H | EVP & Chief Medical Officer | 155 | $0 | $28.29M | 2026-07-16 |
| Meury William | Chief Executive Officer | 9 | $0 | $0 | 2026-07-16 |
| BAKER FELIX | Director, 10% Owner | 72 | $187.65M | $0 | 2026-06-30 |
| High Katherine A | Director | 16 | $0 | $0 | 2026-06-08 |
| FOUSE JACQUALYN A | Director | 39 | $0 | $0 | 2026-06-08 |
| BIENAIME JEAN JACQUES | Director | 58 | $533.4K | $212.9K | 2026-06-08 |
| BRAWLEY OTIS W | Director | 12 | $0 | $0 | 2026-06-08 |
| Upadhyay Suketu | EVP & Chief Financial Officer | 3 | $0 | $0 | 2026-05-04 |
| 667, L.P. | Director, 10% Owner | 81 | $210.20M | $0 | 2026-03-31 |
| Trotta Matteo | EVP, GM, Dermatology US | 12 | $0 | $0 | 2026-03-25 |
| Hoppenot Herve | Special Advisor to the CEO | 95 | $1.91M | $50.85M | 2025-12-08 |
| Denton Sheila A. | EVP & General Counsel | 53 | $0 | $2.14M | 2025-11-17 |
| Iyengar Vijay K | EVP, GMAPPS | 99 | $0 | $8.24M | 2025-07-16 |
| Flannelly Barry P | See Remarks | 140 | $0 | $16.16M | 2025-07-16 |
| Stamoulis Christiana | EVP & Chief Financial Officer | 47 | $0 | $0 | 2025-07-15 |
| SWAIN PAULA J | EVP, Human Resources | 225 | $0 | $60.04M | 2025-07-15 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 85 | $53.55B | $0 | 2025-06-30 |
| Schaffert Susanne | Director | 11 | $0 | $0 | 2025-06-10 |
| Dickinson Jonathan Elliott | EVP, General Manager, Europe | 28 | $0 | $2.02M | 2024-09-12 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 33 | $205 | $0 | 2024-06-28 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | 74 | $0 | $1.87M | 2023-07-14 |
| Pasquale Maria E | EVP & General Counsel | 127 | $0 | $9.67M | 2023-07-14 |
| BAKER JULIAN | Director, 10% Owner | 56 | $107.19M | $0 | 2023-03-13 |
| DIXON WENDY L | Director | 59 | $0 | $6.81M | 2022-03-31 |
| Trower Paul | Principal Accounting Officer | 95 | $0 | $8.64M | 2022-01-19 |
| Wenqing Yao | EVP, Head of Discovery Chem | 119 | $0 | $20.57M | 2021-07-06 |
| FRIEDMAN PAUL A | Director | 122 | $0 | $175.90M | 2020-05-26 |
| BROOKE PAUL A | Director | 55 | $884.8K | $3.07M | 2020-03-31 |
| 14159, L.P. | Director, 10% Owner | 25 | $0 | $0 | 2019-06-06 |
| Huber Reid M | EVP, Chief Scientific Officer | 69 | $0 | $9.61M | 2018-07-16 |
| GRYSKA DAVID W | Executive Vice President, CFO | 45 | $0 | $9.18M | 2018-07-16 |
| Siegel Eric H. | EVP, General Counsel | 186 | $0 | $16.82M | 2017-09-13 |
| Levy Richard S | EVP, Chief Drug Dev&Medical Of | 133 | $0 | $49.81M | 2016-01-06 |
| Daly James M | Exec. VP & Chief Comm. Officer | 125 | $0 | $25.34M | 2015-06-23 |
| Chardonnet Laurent | Other | 70 | $0 | $22.81M | 2015-03-30 |
| ARIKO BARRY A | Director | 24 | $0 | $9.38M | 2015-03-12 |
| DE SCHUTTER RICHARD U | Director | 29 | $725.0K | $11.51M | 2015-03-05 |
| HASTINGS DAVID C | Chief Financial Officer | 57 | $0 | $34.43M | 2014-06-05 |
| WHITFIELD ROY A | Director | 31 | $0 | $6.55M | 2013-12-17 |
| Andrews Patricia S | Chief Commercial Officer | 2 | $0 | $0 | 2012-01-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-10-15 | 2026-10-19 | 925 | — | $0 | 19,431 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-10-15 | 2026-10-19 | 455 | — | $0 | 4,096 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-10-15 | 2026-10-19 | 423 | — | $0 | 3,802 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-10-15 | 2026-10-19 | 839 | — | $0 | 17,627 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-10-15 | 2026-10-19 | 2,642 | $112.71 | $297.8K | 183,200 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-10-15 | 2026-10-19 | 925 | $64.25 | $59.4K | 185,842 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-10-15 | 2026-10-19 | 455 | $61.18 | $27.8K | 184,917 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-10-15 | 2026-10-19 | 423 | $61.76 | $26.1K | 184,462 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-10-15 | 2026-10-19 | 839 | $71.93 | $60.3K | 184,039 | SEC↗ |
| Heeson Lee | EVP, Head of Incyte Intl | F Tax w/h | 2026-10-01 | 2026-10-05 | 463 | $117.14 | $54.2K | 37,578 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award | 2026-09-30 | 2026-10-02 | 206 | $121.35 | $25.0K | 23,225 | SEC↗ |
| Clancy Paul J | Director | A Award | 2026-09-30 | 2026-10-02 | 203 | $121.35 | $24.6K | 25,838 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2026-09-30 | 2026-10-02 | 322 | — | $0 | 28,206,082 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2026-09-30 | 2026-10-02 | 322 | — | $0 | 2,835,403 | SEC↗ |
| Gardner David H | EVP, Chief Strategy Officer | F Tax w/h | 2026-09-22 | 2026-09-24 | 920 | $126.93 | $116.8K | 15,904 | SEC↗ |
| Gardner David H | EVP, Chief Strategy Officer | F Tax w/h | 2026-09-22 | 2026-09-24 | 920 | $126.93 | $116.8K | 15,904 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 9,233 | — | $0 | 18,466 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 4,551 | — | $0 | 4,551 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 6,477 | — | $0 | 20,356 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,957 | — | $0 | 4,225 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 2,957 | $61.76 | $182.6K | 186,157 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 4,551 | $61.18 | $278.4K | 190,708 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 6,477 | $64.25 | $416.1K | 197,185 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 9,233 | $71.93 | $664.1K | 206,418 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-09-15 | 2026-09-17 | 13,985 | $120.49 | $1.69M | 183,200 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-09-15 | 2026-09-17 | 9,233 | $120.50 | $1.11M | 197,185 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 9,233 | — | $0 | 18,466 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 6,477 | — | $0 | 20,356 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 4,551 | — | $0 | 4,551 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-09-15 | 2026-09-17 | 2,957 | — | $0 | 4,225 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-09-15 | 2026-09-17 | 13,985 | $120.49 | $1.69M | 183,200 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-09-15 | 2026-09-17 | 9,233 | $120.50 | $1.11M | 197,185 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 9,233 | $71.93 | $664.1K | 206,418 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 6,477 | $64.25 | $416.1K | 197,185 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 4,551 | $61.18 | $278.4K | 190,708 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-09-15 | 2026-09-17 | 2,957 | $61.76 | $182.6K | 186,157 | SEC↗ |
| Basi Ramitpal K | EVP, Human Resources | F Tax w/h | 2026-08-25 | 2026-08-27 | 504 | $129.72 | $65.4K | 10,993 | SEC↗ |
| Basi Ramitpal K | EVP, Human Resources | F Tax w/h | 2026-08-25 | 2026-08-27 | 504 | $129.72 | $65.4K | 10,993 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-19 | 2026-08-20 | 10,801 | $125.56 | $1.36M | 183,200 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-19 | 2026-08-20 | 10,801 | $125.56 | $1.36M | 183,200 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-12 | 2026-08-14 | 10,803 | $120.04 | $1.30M | 194,001 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-12 | 2026-08-14 | 10,803 | $120.04 | $1.30M | 194,001 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-08-05 | 2026-08-07 | 2,207 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-08-05 | 2026-08-07 | 2,207 | $106.47 | $235.0K | 63,648 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-08-05 | 2026-08-07 | 2,207 | $123.99 | $273.6K | 61,441 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-05 | 2026-08-07 | 10,640 | $122.69 | $1.31M | 204,804 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-08-05 | 2026-08-07 | 2,207 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-08-05 | 2026-08-07 | 2,207 | $123.99 | $273.6K | 61,441 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-08-05 | 2026-08-07 | 2,207 | $106.47 | $235.0K | 63,648 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-08-05 | 2026-08-07 | 10,640 | $122.69 | $1.31M | 204,804 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-08-03 | 2026-08-04 | 6,055 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-08-03 | 2026-08-04 | 6,055 | $120.43 | $729.2K | 61,441 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-08-03 | 2026-08-04 | 6,055 | $105.43 | $638.4K | 67,496 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-08-03 | 2026-08-04 | 6,055 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-08-03 | 2026-08-04 | 6,055 | $120.43 | $729.2K | 61,441 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-08-03 | 2026-08-04 | 6,055 | $105.43 | $638.4K | 67,496 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 326 | — | $0 | 6,055 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 85 | — | $0 | 2,207 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,293 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 1,642 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,623 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 3,023 | — | $0 | 202 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 1,643 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,864 | — | $0 | 191 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,623 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 9,459 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,072 | — | $0 | 2,665 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 3,148 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,709 | — | $0 | 1,233 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,284 | — | $0 | 2,938 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,918 | — | $0 | 1,328 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 3,148 | $68.62 | $216.0K | 74,687 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,709 | $61.76 | $167.3K | 71,539 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,284 | $64.25 | $146.7K | 68,830 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,918 | $61.18 | $178.5K | 66,546 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,293 | $119.41 | $273.8K | 61,441 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 326 | $121.69 | $39.7K | 63,734 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 85 | $122.19 | $10.4K | 64,060 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 1,642 | $119.38 | $196.0K | 64,145 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 1,643 | $119.51 | $196.4K | 65,787 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,864 | $119.40 | $342.0K | 67,430 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 6,171 | $119.43 | $737.0K | 74,989 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,187 | $119.47 | $261.3K | 81,160 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 5,332 | $119.42 | $636.7K | 83,347 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 14,661 | $119.46 | $1.75M | 88,679 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 326 | $105.43 | $34.4K | 103,340 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 85 | $106.47 | $9.0K | 103,014 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,293 | $90.56 | $207.7K | 102,929 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 1,642 | $85.01 | $139.6K | 100,636 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,623 | $83.58 | $219.2K | 98,994 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 3,023 | $83.20 | $251.5K | 96,371 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 1,643 | $80.50 | $132.3K | 93,348 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,864 | $77.67 | $222.4K | 91,705 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,623 | $74.78 | $196.1K | 88,841 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,072 | $71.93 | $149.0K | 76,759 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 9,459 | $72.27 | $683.6K | 86,218 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 4,695 | $119.39 | $560.5K | 70,294 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-07-31 | 2026-08-04 | 15,888 | $119.70 | $1.90M | 215,444 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 326 | — | $0 | 6,055 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 85 | — | $0 | 2,207 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,293 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 1,642 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,623 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 3,023 | — | $0 | 202 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 1,643 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,864 | — | $0 | 191 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,623 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 9,459 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,072 | — | $0 | 2,665 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 3,148 | — | $0 | 0 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,709 | — | $0 | 1,233 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,284 | — | $0 | 2,938 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise deriv | 2026-07-31 | 2026-08-04 | 2,918 | — | $0 | 1,328 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,293 | $119.41 | $273.8K | 61,441 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 326 | $121.69 | $39.7K | 63,734 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 85 | $122.19 | $10.4K | 64,060 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 1,642 | $119.38 | $196.0K | 64,145 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 1,643 | $119.51 | $196.4K | 65,787 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,864 | $119.40 | $342.0K | 67,430 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 4,695 | $119.39 | $560.5K | 70,294 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 6,171 | $119.43 | $737.0K | 74,989 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 2,187 | $119.47 | $261.3K | 81,160 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 5,332 | $119.42 | $636.7K | 83,347 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2026-07-31 | 2026-08-04 | 14,661 | $119.46 | $1.75M | 88,679 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 326 | $105.43 | $34.4K | 103,340 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 85 | $106.47 | $9.0K | 103,014 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,293 | $90.56 | $207.7K | 102,929 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 1,642 | $85.01 | $139.6K | 100,636 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,623 | $83.58 | $219.2K | 98,994 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 3,023 | $83.20 | $251.5K | 96,371 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 1,643 | $80.50 | $132.3K | 93,348 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,864 | $77.67 | $222.4K | 91,705 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,623 | $74.78 | $196.1K | 88,841 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 9,459 | $72.27 | $683.6K | 86,218 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,072 | $71.93 | $149.0K | 76,759 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 3,148 | $68.62 | $216.0K | 74,687 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,709 | $61.76 | $167.3K | 71,539 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,284 | $64.25 | $146.7K | 68,830 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | M Exercise | 2026-07-31 | 2026-08-04 | 2,918 | $61.18 | $178.5K | 66,546 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-07-31 | 2026-08-04 | 15,888 | $119.70 | $1.90M | 215,444 | SEC↗ |
| Heeson Lee | EVP, Head of Incyte Intl | A Award deriv | 2026-07-23 | 2026-07-27 | 13,498 | — | $0 | 13,498 | SEC↗ |
| Heeson Lee | EVP, Head of Incyte Intl | A Award deriv | 2026-07-23 | 2026-07-27 | 15,423 | — | $0 | 15,423 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | A Award deriv | 2026-07-23 | 2026-07-27 | 8,999 | — | $0 | 8,999 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | A Award deriv | 2026-07-23 | 2026-07-27 | 6,426 | — | $0 | 6,426 | SEC↗ |
| Meury William | Chief Executive Officer | A Award deriv | 2026-07-16 | 2026-07-20 | 80,421 | — | $0 | 80,421 | SEC↗ |
| Meury William | Chief Executive Officer | A Award deriv | 2026-07-16 | 2026-07-20 | 77,148 | — | $0 | 77,148 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award deriv | 2026-07-16 | 2026-07-20 | 31,923 | — | $0 | 31,923 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award deriv | 2026-07-16 | 2026-07-20 | 18,487 | — | $0 | 18,487 | SEC↗ |
| Gardner David H | EVP, Chief Strategy Officer | A Award deriv | 2026-07-16 | 2026-07-20 | 31,923 | — | $0 | 31,923 | SEC↗ |
| Gardner David H | EVP, Chief Strategy Officer | A Award deriv | 2026-07-16 | 2026-07-20 | 18,487 | — | $0 | 18,487 | SEC↗ |
| Basi Ramitpal K | EVP, Human Resources | A Award deriv | 2026-07-16 | 2026-07-20 | 12,479 | — | $0 | 12,479 | SEC↗ |
| Basi Ramitpal K | EVP, Human Resources | A Award deriv | 2026-07-16 | 2026-07-20 | 21,548 | — | $0 | 21,548 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A Award deriv | 2026-07-16 | 2026-07-20 | 33,918 | — | $0 | 33,918 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A Award deriv | 2026-07-16 | 2026-07-20 | 19,643 | — | $0 | 19,643 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | A Award deriv | 2026-07-16 | 2026-07-20 | 57,861 | — | $0 | 57,861 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | A Award deriv | 2026-07-16 | 2026-07-20 | 33,508 | — | $0 | 33,508 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | A Award deriv | 2026-07-16 | 2026-07-20 | 14,790 | — | $0 | 14,790 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | A Award deriv | 2026-07-16 | 2026-07-20 | 25,538 | — | $0 | 25,538 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | A Award deriv | 2026-07-16 | 2026-07-20 | 42,298 | — | $0 | 42,298 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | A Award deriv | 2026-07-16 | 2026-07-20 | 24,496 | — | $0 | 24,496 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | A Award deriv | 2026-07-16 | 2026-07-20 | 4,079 | — | $0 | 4,079 | SEC↗ |
| Meury William | Chief Executive Officer | A Award | 2026-07-16 | 2026-07-20 | 26,807 | — | $0 | 183,129 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award | 2026-07-16 | 2026-07-20 | 7,395 | — | $0 | 16,861 | SEC↗ |
| Gardner David H | EVP, Chief Strategy Officer | A Award | 2026-07-16 | 2026-07-20 | 7,395 | — | $0 | 16,824 | SEC↗ |
| Basi Ramitpal K | EVP, Human Resources | A Award | 2026-07-16 | 2026-07-20 | 4,991 | — | $0 | 11,497 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S Sale | 2026-07-16 | 2026-07-20 | 1,093 | $115.01 | $125.7K | 63,940 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A Award | 2026-07-16 | 2026-07-20 | 7,857 | — | $0 | 71,797 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | A Award | 2026-07-16 | 2026-07-20 | 13,403 | — | $0 | 231,332 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | A Award | 2026-07-16 | 2026-07-20 | 5,916 | — | $0 | 63,628 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | A Award | 2026-07-16 | 2026-07-20 | 9,798 | — | $0 | 30,916 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | S Sale | 2026-07-16 | 2026-07-20 | 1,877 | $114.73 | $215.3K | 21,118 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | A Award | 2026-07-16 | 2026-07-20 | 2,834 | — | $0 | 21,699 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of U.S. Commercial | F Tax w/h | 2026-07-15 | 2026-07-16 | 1,099 | $115.09 | $126.5K | 65,033 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | S Sale | 2026-07-15 | 2026-07-16 | 28,237 | $113.05 | $3.19M | 26,083 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | F Tax w/h | 2026-07-15 | 2026-07-16 | 3,088 | $115.09 | $355.4K | 22,995 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | F Tax w/h | 2026-07-15 | 2026-07-16 | 1,098 | $115.09 | $126.4K | 18,865 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | F Tax w/h | 2026-07-15 | 2026-07-16 | 1,512 | $115.09 | $174.0K | 57,712 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | F Tax w/h | 2026-07-15 | 2026-07-16 | 4,950 | $115.09 | $569.7K | 217,929 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | F Tax w/h | 2026-07-14 | 2026-07-16 | 21,830 | $114.88 | $2.51M | 54,320 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | F Tax w/h | 2026-07-14 | 2026-07-16 | 692 | $114.88 | $79.5K | 19,963 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | F Tax w/h | 2026-07-14 | 2026-07-16 | 437 | $114.88 | $50.2K | 59,224 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | F Tax w/h | 2026-07-14 | 2026-07-16 | 17,969 | $114.88 | $2.06M | 222,879 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | F Tax w/h | 2026-07-02 | 2026-07-07 | 2,177 | $116.86 | $254.4K | 76,150 | SEC↗ |
| Meury William | Chief Executive Officer | F Tax w/h | 2026-07-02 | 2026-07-07 | 4,779 | $116.86 | $558.5K | 156,322 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | F Tax w/h | 2026-07-02 | 2026-07-07 | 477 | $116.86 | $55.7K | 20,655 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | F Tax w/h | 2026-07-02 | 2026-07-07 | 350 | $116.86 | $40.9K | 59,661 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award | 2026-06-30 | 2026-07-02 | 255 | $113.36 | $28.9K | 23,019 | SEC↗ |
| Clancy Paul J | Director | A Award | 2026-06-30 | 2026-07-02 | 252 | $113.36 | $28.6K | 25,635 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | A Award | 2026-06-30 | 2026-07-02 | 400 | — | $0 | 28,205,760 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | A Award | 2026-06-30 | 2026-07-02 | 400 | — | $0 | 2,835,081 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| High Katherine A | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| Clancy Paul J | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| BRAWLEY OTIS W | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 12,894 | SEC↗ |
| High Katherine A | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 14,983 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 24,424 | SEC↗ |
| FOUSE JACQUALYN A | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 20,968 | SEC↗ |
| Clancy Paul J | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 25,383 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 22,764 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 2,834,681 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 28,205,360 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise deriv | 2026-06-04 | 2026-06-08 | 2,639 | — | $0 | 0 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise | 2026-06-04 | 2026-06-08 | 2,639 | $83.83 | $221.2K | 23,771 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2026-06-04 | 2026-06-08 | 2,639 | $100.00 | $263.9K | 21,132 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | F Tax w/h | 2026-06-01 | 2026-06-03 | 25,469 | $95.59 | $2.43M | 240,848 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | M Exercise deriv | 2026-05-26 | 2026-05-28 | 15,000 | — | $0 | 0 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | M Exercise | 2026-05-26 | 2026-05-28 | 15,000 | $84.53 | $1.27M | 35,841 | SEC↗ |
| BIENAIME JEAN JACQUES | Director | F Tax w/h | 2026-05-26 | 2026-05-28 | 13,059 | $97.10 | $1.27M | 22,782 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2026-05-26 | 2026-05-28 | 2,051 | $97.35 | $199.7K | 21,132 | SEC↗ |
| Clancy Paul J | Director | M Exercise deriv | 2026-05-19 | 2026-05-21 | 15,000 | — | $0 | 0 | SEC↗ |
| Clancy Paul J | Director | M Exercise | 2026-05-19 | 2026-05-21 | 15,000 | $84.53 | $1.27M | 38,741 | SEC↗ |
| Clancy Paul J | Director | S Sale | 2026-05-19 | 2026-05-21 | 15,000 | $94.93 | $1.42M | 23,741 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | M Exercise deriv | 2026-05-08 | 2026-05-11 | 15,000 | — | $0 | 0 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | M Exercise deriv | 2026-05-08 | 2026-05-11 | 15,000 | — | $0 | 0 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | M Exercise | 2026-05-08 | 2026-05-11 | 15,000 | $84.53 | $1.27M | 28,203,718 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | M Exercise | 2026-05-08 | 2026-05-11 | 15,000 | $84.53 | $1.27M | 2,833,039 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | A Award | 2026-05-06 | 2026-05-20 | 31,517 | — | $0 | 266,317 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | A Award | 2026-05-06 | 2026-05-20 | 44,124 | — | $0 | 78,327 | SEC↗ |
| Upadhyay Suketu | EVP & Chief Financial Office | A Award deriv | 2026-05-04 | 2026-05-06 | 13,171 | — | $0 | 26,342 | SEC↗ |
| Upadhyay Suketu | EVP & Chief Financial Office | A Award deriv | 2026-05-04 | 2026-05-06 | 38,429 | — | $0 | 38,429 | SEC↗ |
| Upadhyay Suketu | EVP & Chief Financial Office | A Award | 2026-05-04 | 2026-05-06 | 26,343 | — | $0 | 26,343 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-04-17 | 2026-04-21 | 12,590 | — | $0 | 27,699 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise deriv | 2026-04-17 | 2026-04-21 | 6,077 | — | $0 | 26,833 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-04-17 | 2026-04-21 | 12,590 | $71.93 | $905.6K | 281,359 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | S Sale | 2026-04-17 | 2026-04-21 | 18,667 | $96.50 | $1.80M | 262,692 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | M Exercise | 2026-04-17 | 2026-04-21 | 6,077 | $64.25 | $390.4K | 268,769 | SEC↗ |
| Stein Steven H | CMO & Head of Late-Stage Dev | A Award | 2026-04-15 | 2026-04-17 | 39,049 | — | $0 | 73,252 | SEC↗ |
| CAGNONI PABLO J | President, Global Head of R& | A Award | 2026-04-15 | 2026-04-17 | 27,892 | — | $0 | 262,692 | SEC↗ |
| Meury William | Chief Executive Officer | M Exercise | 2026-04-15 | 2026-04-17 | 125,000 | — | $0 | 161,101 | SEC↗ |
| Clancy Paul J | Director | A Award | 2026-03-31 | 2026-04-02 | 265 | $94.12 | $24.9K | 23,741 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award | 2026-03-31 | 2026-04-02 | 269 | $94.12 | $25.3K | 21,122 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award | 2026-03-31 | 2026-04-02 | 421 | — | $0 | 2,818,039 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award | 2026-03-31 | 2026-04-02 | 421 | — | $0 | 28,188,718 | SEC↗ |
| Trotta Matteo | EVP, GM, Dermatology US | F Tax w/h | 2026-03-25 | 2026-03-26 | 537 | $92.23 | $49.5K | 14,882 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise deriv | 2026-03-17 | 2026-03-19 | 7,166 | — | $0 | 9,102 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise deriv | 2026-03-17 | 2026-03-19 | 11,501 | — | $0 | 32,910 | SEC↗ |
| CAGNONI PABLO J | President, R&D | S Sale | 2026-03-17 | 2026-03-19 | 18,667 | $94.24 | $1.76M | 234,800 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise | 2026-03-17 | 2026-03-19 | 7,166 | $61.18 | $438.4K | 241,966 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise | 2026-03-17 | 2026-03-19 | 11,501 | $64.25 | $738.9K | 253,467 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise deriv | 2026-02-19 | 2026-02-23 | 5,575 | — | $0 | 16,268 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise deriv | 2026-02-19 | 2026-02-23 | 13,093 | — | $0 | 7,182 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise | 2026-02-19 | 2026-02-23 | 13,093 | $61.76 | $808.6K | 247,893 | SEC↗ |
| CAGNONI PABLO J | President, R&D | S Sale | 2026-02-19 | 2026-02-23 | 18,668 | $100.91 | $1.88M | 234,800 | SEC↗ |
| CAGNONI PABLO J | President, R&D | M Exercise | 2026-02-19 | 2026-02-23 | 5,575 | $61.18 | $341.1K | 253,468 | SEC↗ |
| Heeson Lee | EVP, Head of Incyte Intl | F Tax w/h | 2026-02-02 | 2026-02-04 | 111 | $102.67 | $11.4K | 38,041 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | F Tax w/h | 2026-02-02 | 2026-02-04 | 185 | $102.67 | $19.0K | 34,065 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | F Tax w/h | 2026-01-20 | 2026-01-21 | 429 | $102.62 | $44.0K | 34,250 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | A Award deriv | 2026-01-16 | 2026-01-21 | 4,218 | — | $0 | 4,218 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 2,425 | — | $0 | 2,425 | SEC↗ |
| Trotta Matteo | EVP, GM, Dermatology US | A Award deriv | 2026-01-16 | 2026-01-21 | 8,542 | — | $0 | 8,542 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of US Oncology | A Award deriv | 2026-01-16 | 2026-01-21 | 14,237 | — | $0 | 14,237 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | A Award deriv | 2026-01-16 | 2026-01-21 | 19,932 | — | $0 | 19,932 | SEC↗ |
| CAGNONI PABLO J | President, R&D | A Award deriv | 2026-01-16 | 2026-01-21 | 28,475 | — | $0 | 28,475 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | A Award | 2026-01-16 | 2026-01-21 | 7,426 | — | $0 | 34,679 | SEC↗ |
| Heeson Lee | EVP, Head of Incyte Intl | A Award | 2026-01-16 | 2026-01-21 | 8,911 | — | $0 | 38,152 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of US Oncology | S Sale | 2026-01-07 | 2026-01-08 | 10,856 | $109.07 | $1.18M | 66,132 | SEC↗ |
| Issa Mohamed Khairie | EVP, Head of US Oncology | F Tax w/h | 2026-01-06 | 2026-01-08 | 8,264 | $106.66 | $881.4K | 76,988 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | S Sale | 2026-01-05 | 2026-01-07 | 15,634 | $101.70 | $1.59M | 34,203 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | A Award | 2025-12-31 | 2026-01-05 | 328 | — | $0 | 28,188,297 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | A Award | 2025-12-31 | 2026-01-05 | 328 | — | $0 | 2,817,618 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | F Tax w/h | 2025-12-31 | 2026-01-05 | 254 | $98.77 | $25.1K | 27,253 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | F Tax w/h | 2025-12-31 | 2026-01-05 | 13,292 | $98.77 | $1.31M | 49,837 | SEC↗ |
| HARRIGAN EDMUND | Director | A Award | 2025-12-31 | 2026-01-05 | 245 | $98.77 | $24.2K | 20,853 | SEC↗ |
| Clancy Paul J | Director | A Award | 2025-12-31 | 2026-01-05 | 241 | $98.77 | $23.8K | 23,476 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise deriv | 2025-12-19 | 2025-12-22 | 1,044 | — | $0 | 0 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise deriv | 2025-12-19 | 2025-12-22 | 1,730 | — | $0 | 0 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise | 2025-12-19 | 2025-12-22 | 1,730 | $95.76 | $165.7K | 25,747 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2025-12-19 | 2025-12-22 | 2,774 | $100.00 | $277.4K | 22,973 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | M Exercise | 2025-12-19 | 2025-12-22 | 1,044 | $95.76 | $100.0K | 24,017 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2025-12-18 | 2025-12-22 | 600 | $98.25 | $59.0K | 22,973 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | S Sale | 2025-12-17 | 2025-12-18 | 4,323 | $97.26 | $420.5K | 27,507 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | S Sale | 2025-12-16 | 2025-12-18 | 53,175 | $97.29 | $5.17M | 31,830 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | S Sale | 2025-12-16 | 2025-12-18 | 833 | $97.42 | $81.2K | 85,005 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2025-12-11 | 2025-12-12 | 255 | $94.94 | $24.2K | 60,011 | SEC↗ |
| Mayes Patrick A | EVP & Chief Scientific Offic | S Sale | 2025-12-10 | 2025-12-12 | 5,553 | $95.58 | $530.8K | 60,266 | SEC↗ |
| Hoppenot Herve | Director | F Tax w/h | 2025-12-08 | 2025-12-10 | 2,843 | $96.70 | $274.9K | 326,803 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | S Sale | 2025-12-02 | 2025-12-03 | 20,105 | $102.51 | $2.06M | 63,129 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award deriv | 2025-12-01 | 2025-12-03 | 23,665 | — | $0 | 23,665 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award deriv | 2025-12-01 | 2025-12-03 | 43,301 | — | $0 | 43,301 | SEC↗ |
| Hoffman Richard A. | EVP & General Counsel | A Award | 2025-12-01 | 2025-12-03 | 9,466 | — | $0 | 9,466 | SEC↗ |
| Morrissey Michael James | EVP, Head of Tech. Operation | F Tax w/h | 2025-12-01 | 2025-12-03 | 326 | $102.04 | $33.3K | 85,838 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | F Tax w/h | 2025-12-01 | 2025-12-03 | 17,093 | $102.04 | $1.74M | 83,234 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | S Sale | 2025-12-01 | 2025-12-03 | 2,559 | $102.96 | $263.5K | 100,327 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2025-11-24 | 2025-11-25 | 600 | $103.00 | $61.8K | 23,573 | SEC↗ |
| Tray Thomas | Principal Accounting Officer | S Sale | 2025-11-21 | 2025-11-25 | 169 | $102.00 | $17.2K | 24,173 | SEC↗ |
| Denton Sheila A. | EVP & General Counsel | M Exercise deriv | 2025-11-17 | 2025-11-19 | 278 | — | $0 | 8,883 | SEC↗ |
| Denton Sheila A. | EVP & General Counsel | S Sale | 2025-11-17 | 2025-11-19 | 278 | $104.36 | $29.0K | 26,569 | SEC↗ |
| Denton Sheila A. | EVP & General Counsel | M Exercise | 2025-11-17 | 2025-11-19 | 278 | $64.25 | $17.9K | 26,847 | SEC↗ |
| Hoppenot Herve | Director | S Sale | 2025-11-10 | 2025-11-12 | 187,500 | $105.46 | $19.77M | 329,646 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 2,995 | — | $0 | 0 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 1,044 | — | $0 | 0 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 1,194 | — | $0 | 0 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise | 2025-11-05 | 2025-11-07 | 1,044 | $95.76 | $100.0K | 108,119 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise | 2025-11-05 | 2025-11-07 | 1,194 | $83.83 | $100.1K | 104,080 | SEC↗ |
| Stein Steven H | EVP & Chief Medical Officer | M Exercise | 2025-11-05 | 2025-11-07 | 2,995 | $95.76 | $286.8K | 107,075 | SEC↗ |